{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:37:00Z","timestamp":1795225020459,"version":"4.10.3"},"reference-count":102,"publisher":"Manuscript Technomedia LLP","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Pharma Investig"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2230-973x.176456","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T07:03:22Z","timestamp":1455519802000},"page":"1","source":"Crossref","is-referenced-by-count":260,"title":["Insulin delivery methods: Past, present and future"],"prefix":"10.5530","volume":"6","author":[{"given":"RimaB","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ViralN","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DavidM","family":"Maahs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3478","reference":[{"key":"key-10.4103\/2230-973X.176456-1","unstructured":"The Global Burden. International Diabetes Federation. IDF Diabetes Atlas. 6 th ed. Brussels, Belgium: International Diabetes Federation; 2013. Available from: http:\/\/www.idf.org\/diabetesatlas\/5e\/the-global-burden. [Last accessed on 2013 Sep 16]."},{"key":"key-10.4103\/2230-973X.176456-2","first-page":"901","volume-title":"Use of non-insulin therapies for type 1 diabetes","author":"Garg","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-3","first-page":"A progressive disease","volume-title":"K.prospective diabetes study 16","author":"U","year":"6 ye","journal-title":"Overview of"},{"key":"key-10.4103\/2230-973X.176456-4","first-page":"727","volume-title":"The future of basal insulin","author":"Shah","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-5","first-page":"977","volume-title":"The Diabetes Control and Complications Trial Research Group","author":"The","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-973X.176456-6","first-page":"450","volume-title":"The DCCT Research Group","author":"Epidemiology","year":"1991","journal-title":"Am J Med"},{"key":"key-10.4103\/2230-973X.176456-7","first-page":"1845","volume-title":"Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society","author":"Seaquist","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-973X.176456-8","unstructured":"The history of injecting and the development of the syringe. Exchange supply tools for harm reduction. Available from: http:\/\/www.exchangesupplies.org\/article_history_of_injecting_and_development_of_the_syringe.php. [Last accessed on 2013 Sep 16]."},{"key":"key-10.4103\/2230-973X.176456-9","unstructured":"Milestones BD. Available from: http:\/\/www.bd.com\/aboutbd\/history\/. [Last accessed on 2013 Sep 16]."},{"key":"key-10.4103\/2230-973X.176456-10","first-page":"947","volume-title":"Insulin delivery device technology 2012: Where are we after 90 years?","author":"Fry","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-11","first-page":"116","volume-title":"Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes","author":"Burdick","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"key-10.4103\/2230-973X.176456-12","first-page":"505","volume-title":"Evolution of diabetes insulin delivery devices","author":"Selam","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-13","unstructured":"Novo Nordisk Blue sheet. Quarterly perspective on diabetes and chronic diseases. 2010. Available from: http:\/\/www.press.novonordisk-us.com\/bluesheet-issue2\/downloads\/NovoNordisk_Bluesheet_Newsletter.pdf. [Last accessed on 2014 Sep 13]."},{"key":"key-10.4103\/2230-973X.176456-14","first-page":"S93","volume-title":"Evolution of devices in diabetes management","author":"Penfornis","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-15","first-page":"793","volume-title":"HumaPen Memoir: A novel insulin-injecting pen with a dose-memory feature","author":"Ignaut","year":"2007","journal-title":"Expert Rev Med Devices"},{"key":"key-10.4103\/2230-973X.176456-16","doi-asserted-by":"crossref","unstructured":"Reynholds C, Antal Z. Analysis of the NovoPen Echo for the delivery of insulin: A comparison of usability, functionality and preference among pediatric subjects and their parents, and health care professionals. J Diabetes Sci Technol 2010;4:1476-8.","DOI":"10.1177\/193229681000400623"},{"key":"key-10.4103\/2230-973X.176456-17","first-page":"475","volume-title":"Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals","author":"Pf\u00fctzner","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/2230-973X.176456-18","first-page":"301","volume-title":"Dose accuracy of a durable insulin pen with memory function, before and after simulated lifetime use and under stress conditions","author":"Xue","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"key-10.4103\/2230-973X.176456-19","first-page":"2323","volume-title":"Preference for a new prefilled insulin pen compared with the original pen","author":"Garg","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/2230-973X.176456-20","first-page":"804","volume-title":"Study on the dosing accuracy of commonly used disposable insulin pens","author":"Krzywon","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-21","first-page":"120","volume-title":"Diabetes care - Insulin delivery in a changing world","author":"Marcus","year":"2008","journal-title":"Medscape J Med"},{"key":"key-10.4103\/2230-973X.176456-22","first-page":"430","volume-title":"Factors affecting use of insulin pens by patients with type 2 diabetes","author":"Rubin","year":"2008","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-23","first-page":"1081","volume-title":"Does size matter.Thoughts about insulin pen needles?","author":"Hirsch","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-24","doi-asserted-by":"crossref","unstructured":"Aronson R, Gibney MA, Oza K, B\u00e9rub\u00e9 J, Kassler-Taub K, Hirsch L. Insulin pen needles: Effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther 2013;35:923-33.e4.","DOI":"10.1016\/j.clinthera.2013.05.020"},{"key":"key-10.4103\/2230-973X.176456-25","first-page":"737","volume-title":"Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes","author":"Kreugel","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-26","first-page":"435","volume-title":"Quantitative study of insulin secretion and clearance in normal and obese subjects","author":"Polonsky","year":"1988","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2230-973X.176456-27","first-page":"171","volume-title":"A servomechanism for blood sugar control","author":"Kadish","year":"1963","journal-title":"Biomed Sci Instrum"},{"key":"key-10.4103\/2230-973X.176456-28","first-page":"351","volume-title":"Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care","author":"Maniatis","year":"2001","journal-title":"Pediatrics"},{"key":"key-10.4103\/2230-973X.176456-29","first-page":"50","volume-title":"Is there a place for insulin pump therapy in your practice?","author":"Skyler","year":"2007","journal-title":"Clin Diabetes"},{"key":"key-10.4103\/2230-973X.176456-30","first-page":"2590","volume-title":"Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline A1c","author":"Retnakaran","year":"2004","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-31","first-page":"705","volume-title":"Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials","author":"Pickup","year":"2002","journal-title":"BMJ"},{"key":"key-10.4103\/2230-973X.176456-32","first-page":"493","volume-title":"Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus - a large-scale multicentre pilot study","author":"M\u00fcller-Godeffroy","year":"2009","journal-title":"Diabet Med"},{"key":"key-10.4103\/2230-973X.176456-33","first-page":"1079","volume-title":"Insulin pump therapy: A meta-analysis","author":"Weissberg-Benchell","year":"2003","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-34","first-page":"16","volume-title":"Emerging diabetes therapies and technologies","author":"Moser","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/2230-973X.176456-35","first-page":"574","volume-title":"Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: A prospective 6-month study","author":"Garg","year":"2011","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-36","first-page":"18","volume-title":"Role of continuous glucose monitoring in patients diabetes using multiple daily insulin injection","author":"Garg","year":"2009","journal-title":"Infusystems Int"},{"key":"key-10.4103\/2230-973X.176456-37","first-page":"804","volume-title":"Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: Prospective results from a community and academic practice patient registry","author":"Cohen","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-38","first-page":"311","volume-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-973X.176456-39","first-page":"B40","volume-title":"Dead-in-bed syndrome in young diabetic patients","author":"Sovik","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-40","first-page":"1814","volume-title":"Severe hypoglycemia predicts mortality in diabetes","author":"Cryer","year":"2012","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-41","first-page":"1466","volume-title":"The ASPIRE study: Design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia","author":"Brazg","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-42","first-page":"205","volume-title":"Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: The in-clinic ASPIRE study","author":"Garg","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-43","first-page":"1224","volume-title":"Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system","author":"Beck","year":"2014","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-44","first-page":"1129","volume-title":"Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy","author":"Danne","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-45","first-page":"224","volume-title":"Threshold-based insulin-pump interruption for reduction of hypoglycemia","author":"Bergenstal","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-973X.176456-46","unstructured":"Finn T. Medtronic Unveils FDA-Approved \"Artificial Pancreas\"-T1 Diabetes Patients Need to Take Note.\u202fHealthcare Matters Healthcare Matters. Oct 1, 2013. Available from: http:\/\/www.hcmatters.com\/2013\/10\/medtronic-unveils-fda-approved-artificial-pancreas-t1-diabetes-patients-need-to-take-note\/. [Last accessed on 2013 Oct 27]."},{"key":"key-10.4103\/2230-973X.176456-47","first-page":"477","volume-title":"Closed-loop system in the management of diabetes: Past, present, and future","author":"Shah","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-48","first-page":"1539","volume-title":"Novel non-invasive methods of insulin delivery","author":"Soares","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"key-10.4103\/2230-973X.176456-49","first-page":"71","volume-title":"\u00dcber inhalation von insulin","author":"G\u00e4nsslen","year":"1925","journal-title":"Klin Wochenschr"},{"key":"key-10.4103\/2230-973X.176456-50","first-page":"552","volume-title":"Insulin across respiratory mucosae by aerosol delivery","author":"Wigley","year":"1971","journal-title":"Diabetes"},{"key":"key-10.4103\/2230-973X.176456-51","first-page":"293","volume-title":"Parenteral absorption of insulin from the lung in diabetic children","author":"Elliott","year":"1987","journal-title":"Aust Paediatr J"},{"key":"key-10.4103\/2230-973X.176456-52","first-page":"417","volume-title":"Alternative delivery routes: Inhaled insulin","author":"Heinemann","year":"2002","journal-title":"Diabetes Nutr Metab"},{"key":"key-10.4103\/2230-973X.176456-53","unstructured":"FDA Approved Drug Products. Available from: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails. [Last accessed on 2013 Oct 27]."},{"key":"key-10.4103\/2230-973X.176456-54","first-page":"781","volume-title":"Clinical pharmacokinetics and pharmacodynamics of inhaled insulin","author":"Patton","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/2230-973X.176456-55","first-page":"427","volume-title":"Exubera inhaled insulin in patients with type 1 and type 2 diabetes: The first 12 months","author":"Alabraba","year":"2009","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-56","first-page":"99","volume-title":"Advances in insulin delivery systems and devices: Beyond the vial and syringe","author":"Flood","year":"2006","journal-title":"Insulin"},{"key":"key-10.4103\/2230-973X.176456-57","first-page":"S65","volume-title":"Technosphere insulin technology","author":"Richardson","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-58","first-page":"1231","volume-title":"A review of inhaled technosphere insulin","author":"Neumiller","year":"2010","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/2230-973X.176456-59","first-page":"499","volume-title":"Pulmonary insulin administration using the AERx insulin diabetes system","author":"Thipphawong","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-60","doi-asserted-by":"crossref","unstructured":"Arbit E, Kidron M. Oral insulin: The rationale for this approach and current developments. J Diabetes Sci Technol 2009;3: 562-7.","DOI":"10.1177\/193229680900300322"},{"key":"key-10.4103\/2230-973X.176456-61","unstructured":"Oral Delivery of Insulin: Novel Approaches. Available from: http:\/\/www.cdn.intechopen.com\/pdfs\/40267\/InTech-Oral_delivery_of_insulin_novel_approaches.pdf. [Last accessed on 2013 Nov 10]."},{"key":"key-10.4103\/2230-973X.176456-62","first-page":"784","volume-title":"An overview of natural polymers for oral insulin delivery","author":"Sonia","year":"2012","journal-title":"Drug Discov Today"},{"key":"key-10.4103\/2230-973X.176456-63","first-page":"665","volume-title":"Challenges and advances in nanoparticle-based oral insulin delivery","author":"Ramesan","year":"2009","journal-title":"Expert Rev Med Devices"},{"key":"key-10.4103\/2230-973X.176456-64","first-page":"45","volume-title":"Nanoparticle strategies for the oral delivery of insulin","author":"Damg\u00e9","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"key-10.4103\/2230-973X.176456-65","first-page":"129","volume-title":"Polymeric hydrogels for oral insulin delivery","author":"Chaturvedi","year":"2013","journal-title":"J Control Release"},{"key":"key-10.4103\/2230-973X.176456-66","doi-asserted-by":"crossref","unstructured":"Geho WB, Geho HC, Lau JR, Gana TJ. Hepatic-directed vesicle insulin: A review of formulation development and preclinical evaluation. J Diabetes Sci Technol 2009;3:1451-9.","DOI":"10.1177\/193229680900300627"},{"key":"key-10.4103\/2230-973X.176456-67","first-page":"29","volume-title":"New ways of insulin delivery","author":"Heinemann","year":"2010","journal-title":"Int J Clin Pract Suppl"},{"key":"key-10.4103\/2230-973X.176456-68","first-page":"363","volume-title":"Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration","author":"Sakloetsakun","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"key-10.4103\/2230-973X.176456-69","first-page":"540","volume-title":"Oral colon delivery of insulin with the aid of functional adjuvants","author":"Maroni","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.4103\/2230-973X.176456-70","first-page":"1","volume-title":"Insulin therapies: Current and future trends at dawn","author":"Yaturu","year":"2013","journal-title":"World J Diabetes"},{"key":"key-10.4103\/2230-973X.176456-71","first-page":"1078","volume-title":"Intranasal aerosolized insulin.Mixed-meal studies and long-term use in type I diabetes","author":"Salzman","year":"1985","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-973X.176456-72","first-page":"573","volume-title":"Long-term use of intranasal insulin in insulin-dependent diabetic patients","author":"Frauman","year":"1987","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-73","first-page":"81","volume-title":"Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: A preliminary study","author":"Leary","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"key-10.4103\/2230-973X.176456-74","first-page":"254","volume-title":"Nasal drug delivery - Recent developments and future prospects","author":"Illum","year":"2012","journal-title":"J Control Release"},{"key":"key-10.4103\/2230-973X.176456-75","doi-asserted-by":"crossref","unstructured":"Stote R, Marbury T, Shi L, Miller M, Strange P. Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation. J Diabetes Sci Technol 2010;4:603-9.","DOI":"10.1177\/193229681000400314"},{"key":"key-10.4103\/2230-973X.176456-76","first-page":"112","volume-title":"Intranasal insulin as a therapeutic option in the treatment of cognitive impairments","author":"Benedict","year":"2011","journal-title":"Exp Gerontol"},{"key":"key-10.4103\/2230-973X.176456-77","first-page":"29","volume-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"key-10.4103\/2230-973X.176456-78","doi-asserted-by":"crossref","unstructured":"Heinemann L, Jacques Y. Oral insulin and buccal insulin: A critical reappraisal. J Diabetes Sci Technol 2009;3:568-84.","DOI":"10.1177\/193229680900300323"},{"key":"key-10.4103\/2230-973X.176456-79","first-page":"1","volume-title":"Emerging trends in insulin delivery: Buccal route","author":"Kumria","year":"2011","journal-title":"J Diabetol"},{"key":"key-10.4103\/2230-973X.176456-80","unstructured":"Generex & Lilly dissolve Oralin Insulin Spray collaboration. Available from: http:\/\/www.islet.org\/forum029\/messages\/26908.htm. [Last accessed on 2013 Nov 10]."},{"key":"key-10.4103\/2230-973X.176456-81","doi-asserted-by":"crossref","unstructured":"World\u2032s First Oral Insulin Spray Launched in India. Asia Pacific Biotech News 2008;12:60. Available from: http:\/\/www.worldscientific.com\/doi\/abs\/10.1142\/S0219030308000918. [Last accessed on 2013 Nov 10].","DOI":"10.1142\/S0219030308000657"},{"key":"key-10.4103\/2230-973X.176456-82","unstructured":"Generex Provides Update on Generex Oral-ly Conference Call. PR News wire. WORCESTER, Mass. and TORONTO, Sept. 27, 2013. Available from: http:\/\/www.prnewswire.com\/news-releases\/generex-provides-update-on-generex-oral-lyn-conference-call-225497092.html. [Last accessed on 2013 Nov 10]."},{"key":"key-10.4103\/2230-973X.176456-83","first-page":"67","volume-title":"Orally dissolving strips: A new approach to oral drug delivery system","author":"Bala","year":"2013","journal-title":"Int J Pharm Investig"},{"key":"key-10.4103\/2230-973X.176456-84","first-page":"1261","volume-title":"Transdermal drug delivery","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"key-10.4103\/2230-973X.176456-85","first-page":"339","volume-title":"Iontophoresis-based transdermal delivery systems","author":"Kanikkannan","year":"2002","journal-title":"BioDrugs"},{"key":"key-10.4103\/2230-973X.176456-86","first-page":"689","volume-title":"Sonophoresis: Recent advancements and future trends","author":"Rao","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/2230-973X.176456-87","first-page":"2110","volume-title":"Transdermal insulin delivery using microdermabrasion","author":"Andrews","year":"2011","journal-title":"Pharm Res"},{"key":"key-10.4103\/2230-973X.176456-88","first-page":"125","volume-title":"Electroporation: An avenue for transdermal drug delivery","author":"Charoo","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"key-10.4103\/2230-973X.176456-89","first-page":"355","volume-title":"Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery","author":"Malakar","year":"2012","journal-title":"Saudi Pharm J"},{"key":"key-10.4103\/2230-973X.176456-90","first-page":"780","volume-title":"Increasing local blood flow by warming the application site: Beneficial effects on postprandial glycemic excursions","author":"Freckmann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-91","first-page":"320","volume-title":"Clinical performance of a device that applies local heat to the insulin infusion site: A crossover study","author":"Freckmann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-92","first-page":"914","volume-title":"Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: Experience with subcutaneous injection and continuous infusion","author":"Vaughn","year":"2011","journal-title":"Endocr Pract"},{"key":"key-10.4103\/2230-973X.176456-93","first-page":"11","volume-title":"Microneedles: An emerging transdermal drug delivery system","author":"Bariya","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/2230-973X.176456-94","first-page":"691","volume-title":"Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas)","author":"Botz","year":"1976","journal-title":"Diabetes"},{"key":"key-10.4103\/2230-973X.176456-95","unstructured":"Van Dijk P. Intraperitoneal insulin. Diapedia the Living Textbook of Diabetes. 2013. Available from: http:\/\/www.diapedia.org\/type-1-diabetes-mellitus\/2104588419\/intraperitoneal-insulin. [Last accessed on 2013 Nov 12]."},{"key":"key-10.4103\/2230-973X.176456-96","first-page":"735","volume-title":"Insulin delivery route for the artificial pancreas: Subcutaneous, intraperitoneal, or intravenous.Pros and cons?","author":"Renard","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"key-10.4103\/2230-973X.176456-97","first-page":"602","volume-title":"Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: The EVADIAC experience","author":"Gin","year":"2003","journal-title":"Diabetes Metab"},{"key":"key-10.4103\/2230-973X.176456-98","first-page":"159","volume-title":"Closed-loop insulin delivery: Towards improved diabetes care","author":"Kumareswaran","year":"2012","journal-title":"Discov Med"},{"key":"key-10.4103\/2230-973X.176456-99","first-page":"565","volume-title":"Delivery of systemic regular insulin via the ocular route in cats","author":"Morgan","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2230-973X.176456-100","first-page":"645","volume-title":"Rectal delivery system for insulin","author":"Ritschel","year":"1988","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key-10.4103\/2230-973X.176456-101","first-page":"454","volume-title":"The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects","author":"Yamasaki","year":"1981","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-973X.176456-102","first-page":"1273","volume-title":"Uber die wirkung intratrachealer zuf\u00fchrung von insulin","author":"Laqueur","year":"1924","journal-title":"Klin Wochenschr"}],"container-title":["International Journal of Pharmaceutical Investigation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:10:21Z","timestamp":1771578621000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpionline.org\/article\/6\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["176456"],"URL":"https:\/\/doi.org\/10.4103\/2230-973x.176456","relation":{},"ISSN":["2230-973X"],"issn-type":[{"value":"2230-973X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}